Clinical Pharmacology Compounding Diabetes 
Eye on FDA
JANUARY 5, 2022
Of the ten AdComm meetings considering new product approvals, companies got a recommendation for approval in half of them, two of them in diabetes. FDA Outcomes. FDA has acted on seven of these recommendations; Neither of the two oncology filings got a recommendation for approval.
RX Note
JANUARY 21, 2023
Adverse Drug Reaction Drug Induced Diseases, 2018 Meyler's Side Effects of Drugs, 2015 Antibiotics The Sanford Guide to Antimicrobial Therapy, 2022 Breastfeeding Briggs' Drugs in Pregnancy and Lactation, 2021 Hale's Medications and Mothers' Milk, 2021 Clinical Practice Applied Therapeutics, 2018 Conn’s Current Therapy, 2022 Current Medical Diagnosis (..)
Expert insights. Personalized for you.
76 
Let's personalize your content